Plain-English translation of NCT07288333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help people hospitalized with schizophrenia feel better and manage their symptoms. Researchers want to compare the medication at two different doses against placebo (an inactive pill) to learn whether it actually works and whether it's safe to use.
Schizophrenia can cause serious symptoms that sometimes require hospitalization, and current treatments don't work well enough for everyone. This trial is exploring whether this new medication might offer another option for people experiencing a crisis or relapse of their symptoms.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to receive either the new medication at a lower dose, the medication at a higher dose, or a placebo—and neither you nor the researchers will know which one you're getting. You'll take your assigned treatment while you're in the hospital and during follow-up visits, and the research team will monitor your symptoms, safety, and how your body responds to the treatment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Bulgaria
United Kingdom